Brendan P. O

Brendan O'Grady Biography and Net Worth

Insider of American Well
Brendan O’Grady is a healthcare industry veteran with over 30 years of experience. Much of his career has concentrated on creating and implementing innovative solutions and teams to drive organizational growth and to advance healthcare access through medicine. As Chief Commercial & Growth Officer at Amwell Brendan is responsible for driving strategic growth initiatives and leading the business development, sales and commercial enablement, marketing, channel partner, and account management teams. His charge is to accelerate and support the expansion of Amwell across geographies and new markets, as well as to identify new pathways for growth. Brendan’s prior experience includes the role President and CEO of Teva Pharmaceuticals’ North America Business, where he was responsible for managing and scaling the productivity, profitability, and overall growth of all Teva’s North American business operations. Prior to this, he was Chief Commercial Officer for Teva Pharmaceutical’s Global Specialty Medicine division and the interim head of Teva’s European Specialty business. Brendan also held the positions of President & CEO of North America Generic Medicines and Senior Vice President and Head of US Market Access & Patient Services for Teva’s U.S. specialty business. Prior to his time at Teva, Brendan spent 10 years with Sanofi predecessor companies in a variety of commercial and medical affairs roles. He received his Bachelor of Science degree from Geneseo State University (SUNY) in Management Science and Marketing and holds a Master of Business Administration from Baker University in Baldwin City, Kansas.

How do I contact Brendan P. O'Grady?

The corporate mailing address for Mr. O'Grady and other American Well executives is 75 STATE STREET 26TH FLOOR, Boston MA, 02109. American Well can also be reached via phone at 617-205-3500 and via email at [email protected] Learn More on Brendan P. O'Grady's contact information.

Has Brendan P. O'Grady been buying or selling shares of American Well?

Brendan P. O'Grady has not been actively trading shares of American Well in the last ninety days. Most recently, Brendan P. Ogrady sold 13,894 shares of the business's stock in a transaction on Wednesday, December 1st. The shares were sold at an average price of $6.50, for a transaction totalling $90,311.00. Learn More on Brendan P. O'Grady's trading history.

Who are American Well's active insiders?

American Well's insider roster includes Keith Anderson (CFO), Bradford Gay (VP), Amber Howe (Insider), Deborah Jackson (Director), Kurt Knight (COO), Serkan Kutan (CTO), Paul McNeice (VP), Jason Medeiros (Insider), Mary Modahl (CMO), Brendan O'Grady (Insider), Deval Patrick (Director), Ido Schoenberg (CEO), and Roy Schoenberg (CEO). Learn More on American Well's active insiders.

Are insiders buying or selling shares of American Well?

During the last twelve months, insiders at the sold shares 46 times. They sold a total of 2,042,009 shares worth more than $10,055,497.29. The most recent insider tranaction occured on September, 21st when CEO Roy Schoenberg sold 125,508 shares worth more than $469,399.92. Insiders at American Well own 13.9 % of the company. Learn More about insider trades at American Well.

Information on this page was last updated on 9/21/2022.

Brendan P. O'Grady Insider Trading History at American Well

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/1/2021Sell13,894$6.50$90,311.00View SEC Filing Icon  
See Full Table

Brendan P. O'Grady Buying and Selling Activity at American Well

This chart shows Brendan P Ogrady's buying and selling at American Well by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

American Well Company Overview

American Well logo
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $3.54
Low: $3.43
High: $3.72

50 Day Range

MA: $4.42
Low: $3.54
High: $5.30

2 Week Range

Now: $3.54
Low: $2.52
High: $10.27

Volume

1,683,500 shs

Average Volume

2,499,267 shs

Market Capitalization

$968.43 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A